Recent Material Events - Tapestry Pharm (TPPH)

Filing Date	Description
2008-06-06	On May 28, 2008, Tapestry Pharmaceuticals, Inc. (the “Company”) entered into a Settlement Agreement (the “Settlement”) with 2945 Wilderness Place, Ltd. (“Lessor”) in order to resolve claims relating to a lease agreement ...
2008-04-08	As previously disclosed in our current report on Form 8-K filed on February 12, 2008, we have significantly curtailed our operations and have been working diligently to convert assets to cash for the settlement of amounts owed to creditors. As part o ...
2008-03-07	On March 3, 2008, Eric K. Rowinsky, MD, resigned from the Board of Directors of Tapestry Pharmaceuticals, Inc. ...
2008-02-12	Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. ...
2008-02-12	As described below under Item 2.05 of this Report, we have effected a reduction in our operations. In connection with such reduction, we terminated the employment period under our employment agreements with Leonard P. Shaykin (Chief Executive Officer ...
2008-02-08	On February 5, 2008, Robert Pollack, Ph. D., resigned from the Board of Directors after seven years of service. Dr. Pollack informed the Company that his resignation is due to medical issues which could potentially interfere with his duties as a Tape ...
2007-12-21	On December 18, 2007, Tapestry Pharmaceuticals, Inc. (“Tapestry”) received notice from The Nasdaq Stock Market, Inc. (“Nasdaq”) that its minimum bid price had fallen below $1.00 for 30 consecutive business days and that its securi ...
2007-12-07	Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. ...
2007-12-04	Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. ...
2007-11-06	The Company’s executive officers intend to conduct meetings with investors, stockholders and analysts and at investor conferences on or after November 5, 2007. A copy of the portion of the presentation materials to be used at those meetings and ...